>
pdufa.bio

BEAM-302

Updated ยทnext FDA decision on the calendar

BEAM-302 is a Beam Therapeutics Inc. program. Its next catalyst is a Readout in Dec 2026. Every date links its source.

BEAM catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Beam Therapeutics Inc. (BEAM). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026BEAM

Questions

When is BEAM-302's next FDA decision or readout?

The next tracked catalyst for BEAM-302 is a Readout in Dec 2026.

What happened at BEAM-302's most recent FDA decision?

No FDA decision for BEAM-302 is in our archive yet.

Who makes BEAM-302?

Beam Therapeutics Inc. (BEAM).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.